References
- CobinRHFutterweitWGinzburgSBfor AACE Menopause Guidelines Revision Task ForceAmerican Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopauseEndocr Pract20061231533716772207
- North American Menopause SocietyEstrogen and progestogen use in peri-and postmenopausal women: July 2008 position statement of The North American Menopause SocietyMenopause20081558460218580541
- PanayNKaluEManagement of premature ovarian failureBest Pract Res Clin Obstet Gynaecol200923129140 Epub December 16, 200819091633
- NelsonHDCommonly used types of postmenopausal estrogen for treatment of hot flashes: scientific reviewJAMA20042911610162015069049
- BalfourJAHeelRCTransdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaintsDrugs1990405615822083514
- FauconnierARingaVDelanoëDFalissardBBréartGUse of hormone replacement therapy: women’s representations of menopause and beauty care practicesMaturitas20003521522810936738
- HunterMSO’DeaIBrittenNDecision-making and hormone replacement therapy: a qualitative analysisSoc Sci Med199745154115489351144
- http://www.wma.net [homepage on the Internet]World Medical AssociationDeclaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects [5 pages] Available from http://www.wma.net/en/30publications/10policies/b3/17c.pdfAccessed January 10, 2012
- FrenkelYKopernikGLazerSAcceptability and skin reactions to transdermal estrogen replacement therapy in relation to climateMaturitas19942031367877518
- BusterJEKoltunWDPascualMLGDayWWPetersonCLow- dose estradiol spray to treat vasomotor symptomsObstet Gynecol20081111343135118515518
- SimonJAEstradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptomsMenopause20061322223116645536